OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease
Raffaella Franca, Debora Curci, Marianna Lucafò, et al.
Expert Opinion on Drug Metabolism & Toxicology (2019) Vol. 15, Iss. 7, pp. 527-539
Open Access | Times Cited: 23
Raffaella Franca, Debora Curci, Marianna Lucafò, et al.
Expert Opinion on Drug Metabolism & Toxicology (2019) Vol. 15, Iss. 7, pp. 527-539
Open Access | Times Cited: 23
Showing 23 citing articles:
The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update
Patrick F. van Rheenen, Marina Aloi, Amit Assa, et al.
Journal of Crohn s and Colitis (2020) Vol. 15, Iss. 2, pp. 171-194
Open Access | Times Cited: 482
Patrick F. van Rheenen, Marina Aloi, Amit Assa, et al.
Journal of Crohn s and Colitis (2020) Vol. 15, Iss. 2, pp. 171-194
Open Access | Times Cited: 482
SIRT2 Contributes to the Regulation of Intestinal Cell Proliferation and Differentiation
Chang Li, Yuning Zhou, Piotr G. Rychahou, et al.
Cellular and Molecular Gastroenterology and Hepatology (2020) Vol. 10, Iss. 1, pp. 43-57
Open Access | Times Cited: 44
Chang Li, Yuning Zhou, Piotr G. Rychahou, et al.
Cellular and Molecular Gastroenterology and Hepatology (2020) Vol. 10, Iss. 1, pp. 43-57
Open Access | Times Cited: 44
Ketogenesis alleviates TNFα-induced apoptosis and inflammatory responses in intestinal cells
Ji Tae Kim, Dana Napier, Jinhwan Kim, et al.
Free Radical Biology and Medicine (2021) Vol. 172, pp. 90-100
Open Access | Times Cited: 28
Ji Tae Kim, Dana Napier, Jinhwan Kim, et al.
Free Radical Biology and Medicine (2021) Vol. 172, pp. 90-100
Open Access | Times Cited: 28
Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases
Konstantinos Papamichael, Gabriele Stocco, Ainhoa Ruiz del Agua
Therapeutic Drug Monitoring (2023) Vol. 45, Iss. 5, pp. 579-590
Open Access | Times Cited: 10
Konstantinos Papamichael, Gabriele Stocco, Ainhoa Ruiz del Agua
Therapeutic Drug Monitoring (2023) Vol. 45, Iss. 5, pp. 579-590
Open Access | Times Cited: 10
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease
Debora Curci, Marianna Lucafò, Adriana Cifù, et al.
Clinical and Translational Science (2021) Vol. 14, Iss. 6, pp. 2184-2192
Open Access | Times Cited: 16
Debora Curci, Marianna Lucafò, Adriana Cifù, et al.
Clinical and Translational Science (2021) Vol. 14, Iss. 6, pp. 2184-2192
Open Access | Times Cited: 16
Medical management of pediatric inflammatory bowel disease
Brad Pasternak
Seminars in Pediatric Surgery (2024) Vol. 33, Iss. 2, pp. 151398-151398
Closed Access | Times Cited: 1
Brad Pasternak
Seminars in Pediatric Surgery (2024) Vol. 33, Iss. 2, pp. 151398-151398
Closed Access | Times Cited: 1
Adalimumab Therapy in Pediatric Crohn Disease: A 2-Year Follow-Up Comparing “Top-Down” and “Step-Up” Strategies
Elise Payen, Antoine Neuraz, Letizia Zenzeri, et al.
Journal of Pediatric Gastroenterology and Nutrition (2022) Vol. 76, Iss. 2, pp. 166-173
Closed Access | Times Cited: 8
Elise Payen, Antoine Neuraz, Letizia Zenzeri, et al.
Journal of Pediatric Gastroenterology and Nutrition (2022) Vol. 76, Iss. 2, pp. 166-173
Closed Access | Times Cited: 8
Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases
Tatjana Welzel, Klervi Golhen, Andrew Atkinson, et al.
Pediatric Rheumatology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Tatjana Welzel, Klervi Golhen, Andrew Atkinson, et al.
Pediatric Rheumatology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Monoclonal antibodies against pediatric ulcerative colitis: a review of clinical progress
Debora Curci, Marianna Lucafò, Giuliana Decorti, et al.
Expert Opinion on Biological Therapy (2024)
Closed Access | Times Cited: 1
Debora Curci, Marianna Lucafò, Giuliana Decorti, et al.
Expert Opinion on Biological Therapy (2024)
Closed Access | Times Cited: 1
Barbaloin Attenuates Mucosal Damage in Experimental Models of Rat Colitis by Regulating Inflammation and the AMPK Signaling Pathway
Ling Gai, Likai Chu, Rui Xia, et al.
Medical Science Monitor (2019) Vol. 25, pp. 10045-10056
Open Access | Times Cited: 13
Ling Gai, Likai Chu, Rui Xia, et al.
Medical Science Monitor (2019) Vol. 25, pp. 10045-10056
Open Access | Times Cited: 13
Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn's Disease: A Post Hoc Analysis of the REACH Trial
Adam S. Cheifetz, Niels Vande Casteele, Zhongya Wang, et al.
The American Journal of Gastroenterology (2022) Vol. 118, Iss. 3, pp. 485-490
Open Access | Times Cited: 5
Adam S. Cheifetz, Niels Vande Casteele, Zhongya Wang, et al.
The American Journal of Gastroenterology (2022) Vol. 118, Iss. 3, pp. 485-490
Open Access | Times Cited: 5
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease
Debora Curci, Marianna Lucafò, Pietro Parisse, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 948-948
Open Access | Times Cited: 4
Debora Curci, Marianna Lucafò, Pietro Parisse, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 948-948
Open Access | Times Cited: 4
One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study
Stefania Cheli, Diego Savino, Annalisa De Silvestri, et al.
The Pharmacogenomics Journal (2023) Vol. 23, Iss. 5, pp. 112-118
Open Access | Times Cited: 2
Stefania Cheli, Diego Savino, Annalisa De Silvestri, et al.
The Pharmacogenomics Journal (2023) Vol. 23, Iss. 5, pp. 112-118
Open Access | Times Cited: 2
Infliximab in inflammatory bowel disease. Is premedication necessary?
Paulina Nuñez F., Rodrigo Quera, Daniela Simian, et al.
Gastroenterología y Hepatología (English Edition) (2021)
Closed Access | Times Cited: 4
Paulina Nuñez F., Rodrigo Quera, Daniela Simian, et al.
Gastroenterología y Hepatología (English Edition) (2021)
Closed Access | Times Cited: 4
High anti‐TNFα Concentrations Are Not Associated With More Adverse Events in Pediatric Inflammatory Bowel Disease
Maya Zvuloni, Manar Matar, Rachel Levi, et al.
Journal of Pediatric Gastroenterology and Nutrition (2021) Vol. 73, Iss. 6, pp. 717-721
Closed Access | Times Cited: 4
Maya Zvuloni, Manar Matar, Rachel Levi, et al.
Journal of Pediatric Gastroenterology and Nutrition (2021) Vol. 73, Iss. 6, pp. 717-721
Closed Access | Times Cited: 4
Infliximab en enfermedad inflamatoria intestinal. ¿Es necesario premedicar?
Paulina Nuñez F., Rodrigo Quera, Daniela Simian, et al.
Gastroenterología y Hepatología (2020) Vol. 44, Iss. 5, pp. 321-329
Closed Access | Times Cited: 3
Paulina Nuñez F., Rodrigo Quera, Daniela Simian, et al.
Gastroenterología y Hepatología (2020) Vol. 44, Iss. 5, pp. 321-329
Closed Access | Times Cited: 3
Therapeutic drug monitoring for biological medications in inflammatory bowel disease
Rachel C. Cogan, Basem W. El-Matary, Wael El‐Matary
Saudi Journal of Gastroenterology (2022) Vol. 28, Iss. 5, pp. 322-331
Open Access | Times Cited: 2
Rachel C. Cogan, Basem W. El-Matary, Wael El‐Matary
Saudi Journal of Gastroenterology (2022) Vol. 28, Iss. 5, pp. 322-331
Open Access | Times Cited: 2
The Association Between Genetic Variants, Pharmacokinetics, and Infliximab Efficacy in Pediatric Patients With Crohn's Disease in China
Wenhui Hu, Yan Feng, Ziqing Ye, et al.
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 2
Wenhui Hu, Yan Feng, Ziqing Ye, et al.
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 2
Adalimumab in the treatment of pediatric patients with chronic noninfectious anterior uveitis
Jeanne Martine Gunzinger, Phoebe Moore, Athimalaipet V Ramanan, et al.
Expert Review of Ophthalmology (2021) Vol. 16, Iss. 4, pp. 231-241
Open Access | Times Cited: 1
Jeanne Martine Gunzinger, Phoebe Moore, Athimalaipet V Ramanan, et al.
Expert Review of Ophthalmology (2021) Vol. 16, Iss. 4, pp. 231-241
Open Access | Times Cited: 1
Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical Practice
Marta Calvo, Yago González Lama, Belén Ruíz‐Antorán, et al.
Crohn s & Colitis 360 (2023) Vol. 5, Iss. 1
Open Access
Marta Calvo, Yago González Lama, Belén Ruíz‐Antorán, et al.
Crohn s & Colitis 360 (2023) Vol. 5, Iss. 1
Open Access
One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study
Emilio Clementi, Stefania Cheli, Diego Savino, et al.
Research Square (Research Square) (2023)
Open Access
Emilio Clementi, Stefania Cheli, Diego Savino, et al.
Research Square (Research Square) (2023)
Open Access
Therapeutic drug monitoring: Fundamentals and optimization
Ahmed S. Ali, Mahran S. Abdel-Rahman, Mohammed A. Bazuhair
Drug Discovery (2023), pp. 1-11
Open Access
Ahmed S. Ali, Mahran S. Abdel-Rahman, Mohammed A. Bazuhair
Drug Discovery (2023), pp. 1-11
Open Access
Strengthened monitoring and optimized management of Crohn’s disease patients
Jingjing Wang, Yihong Fan, Rong Huang
Shijie huaren xiaohua zazhi (2020) Vol. 28, Iss. 15, pp. 660-668
Open Access
Jingjing Wang, Yihong Fan, Rong Huang
Shijie huaren xiaohua zazhi (2020) Vol. 28, Iss. 15, pp. 660-668
Open Access
